This Senator Just Blasted His GOP Colleagues for Ignoring the Opioid Epidemic

”If this becomes law, there is no Narcan for Medicaid. Once it’s cut by Trumpcare, it is dead.”

Sen. Ed Markey (D-Mass.) took to the Senate floor Monday night to blast his Republican colleagues for attempting to pass a health care bill that, amid a spiraling nationwide opioid epidemic, could eliminate insurance coverage for thousands of Americans that depend on it for addiction treatment. Markey pointed to the GOP’s efforts to cut Medicaid funding as particularly harmful for individuals dealing with an opioid addiction (the House’s health care bill included $834 billion in reductions to Medicaid spending).

“If this becomes law, there is no Narcan for Medicaid,” Markey said, referring to the brand name for naloxone, the overdose reversal medication. “Once it’s cut by Trumpcare, it is dead. Those devastating cuts would grind the progress we’ve made in expanding access to opioid treatment to a screeching halt and kick people currently in treatment to the curb.”

Senate Republicans are working on their bill to repeal Obamacare behind closed doors, so the details of how it would effect drug users in recovery are unknown. But an estimated 2.8 million Americans with a substance abuse disorder, including 220,000 who are addicted to opioids, would lose some or all of their insurance coverage if Obamacare is repealed, according to an analysis by researchers Richard Frank of Harvard Medical School and Sherry Glied of New York University. The Congressional Budget Office found that if a version of Trumpcare that passed the House last month became law, addiction treatment services “could increase by thousands of dollars in a given year” for those who aren’t covered by insurance through their employers.

BEFORE YOU CLICK AWAY!

December is make or break for us. A full one-third of our annual fundraising comes in this month alone. A strong December means our newsroom is on the beat and reporting at full strength. A weak one means budget cuts and hard choices ahead.

The December 31 deadline is closing in fast. To reach our $400,000 goal, we need readers who’ve never given before to join the ranks of MoJo donors. And we need our steadfast supporters to give again today—any amount.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do.

That’s why we need you right now. Please chip in to help close the gap.

BEFORE YOU CLICK AWAY!

December is make or break for us. A full one-third of our annual fundraising comes in this month alone. A strong December means our newsroom is on the beat and reporting at full strength. A weak one means budget cuts and hard choices ahead.

The December 31 deadline is closing in fast. To reach our $400,000 goal, we need readers who’ve never given before to join the ranks of MoJo donors. And we need our steadfast supporters to give again today—any amount.

Managing an independent, nonprofit newsroom is staggeringly hard. There’s no cushion in our budget—no backup revenue, no corporate safety net. We can’t afford to fall short, and we can’t rely on corporations or deep-pocketed interests to fund the fierce, investigative journalism Mother Jones exists to do.

That’s why we need you right now. Please chip in to help close the gap.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate